MCOLN2 and glioblastoma: The functional role of TRPML2 in GBM was evaluated by silencing and enforcing TRPML2 expression as well as by triggering TRPML2 with the specific agonist, ML2-SA1 [15], in T98 and U251 cell lines previously characterized for TRPML2 expression [2].